Research and Markets has announced the addition of the "Global Asthma Epidemiology and Patient Flow Analysis - 2017" report to their offering.

The results of the Asthma patients study are announced in this new report Global Asthma Epidemiology and Patient Flow Analysis - 2017'. The report provides insights into Asthma epidemiology, Asthma diagnosed patients, and Asthma treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Asthma derived from epidemiological analysis, percentage of patients diagnosed with Asthma, and percentage of patients treated with a therapy.

The study helps executives estimate Asthma market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Asthma prevalence, Asthma diagnosis rate, and Asthma treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Asthma Patient Flow
  • Asthma Prevalence
  • Asthma Diagnosed Patients
  • Asthma Treated Patients

Key Topics Covered:

1. Asthma: Disease Definition

2. Global Asthma Patient Flow

3. Asthma Patient Flow in the US

4. Asthma Patient Flow in Europe

5. Asthma Patient Flow in Germany

6. Asthma Patient Flow in France

7. Asthma Patient Flow in Spain

8. Asthma Patient Flow in Italy

9. Asthma Patient Flow in UK

10. Asthma Patient Flow in Japan

11. Research Methodology

For more information about this report visit http://www.researchandmarkets.com/research/5zxcsq/global_asthma